1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. KORRO BIO INC.
Korro Bio Inc.
XNAS: KRRO
Download real time
13.57 0.08 (0.59%)
75.72% Fall from 52W High
74,971
XNAS Volume

XNAS 01 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Korro Bio Inc is on 07 May 2026 for the purpose of Korro Bio Inc First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Korro Bio Inc

The latest disclosure was made by Ali Behbahani in Korro Bio Inc where a trade of 242,945 Pre-Funded Warrants done was reported to US exchanges on March 10, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ali Behbahani Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2026 242,945 242,945 - - Pre-Funded Warrants
Ali Behbahani Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 11.11 per share. 10 Mar 2026 207,100 1,297,893 - 11.1 2,300,881 Common Stock
Loic A Vincent Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2026 35,000 35,000 - - Stock Option (Right to Buy)
Oliver Dolan Senior Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2026 15,000 15,000 - - Stock Option (Right to Buy)
Jeffrey Cerio General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2026 23,000 23,000 - - Stock Option (Right to Buy)
Todd Chappell Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2026 38,000 38,000 - - Stock Option (Right to Buy)
Ram Aiyar Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2026 40,000 40,000 - 0 Common Stock
Ram Aiyar Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Feb 2026 80,000 80,000 - - Stock Option (Right to Buy)
Loic A Vincent Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2025 21,715 21,715 - 0 Common Stock
Oliver Dolan Senior Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2025 21,482 21,482 - 0 Common Stock
Jeffrey Cerio General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2025 41,902 41,902 - 0 Common Stock
Todd Chappell Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Dec 2025 20,132 20,132 - 0 Common Stock
Rachel Meyers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 6,010 6,010 - - Stock Option (Right to Buy)
Jean-Francois Formela Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 6,010 6,010 - - Stock Option (Right to Buy)
Timothy R. Pearson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 6,010 6,010 - - Stock Option (Right to Buy)
Ali Behbahani Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 6,010 6,010 - - Stock Option (Right to Buy)
Nessan Bermingham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 6,010 6,010 - - Stock Option (Right to Buy)
Katharine Knobil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2025 6,010 6,010 - - Stock Option (Right to Buy)
Loic A Vincent Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2025 70,000 70,000 - - Stock Option (Right to Buy)
Oliver Dolan Senior Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2025 20,000 20,000 - - Stock Option (Right to Buy)
Jeffrey Cerio General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 29,000 29,000 - - Stock Option (Right to Buy)
Olukemi Olugemo Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 42,000 42,000 - - Stock Option (Right to Buy)
Todd Chappell Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 34,500 34,500 - - Stock Option (Right to Buy)
Vineet Agarwal Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 30,000 30,000 - - Stock Option (Right to Buy)
Ram Aiyar Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 100,000 100,000 - - Stock Option (Right to Buy)
Vineet Agarwal Chief Financial Officer 11 Nov 2024 800 30,807 - - Stock Option (Right to Buy)
Vineet Agarwal Chief Financial Officer 11 Nov 2024 800 0 - 70 56,000 Common Stock
Vineet Agarwal Chief Financial Officer 11 Nov 2024 800 800 - 11.7 9,344 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 115 7,914 - 74.6 8,575 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 953 45,594 - - Stock Option (Right to Buy)
Vineet Agarwal Chief Financial Officer 17 Oct 2024 2,023 8,193 - 71.5 144,663 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 164 8,029 - 73.7 12,089 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 56 7,858 - 76 4,256 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 23 7,835 - 77 1,771 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 260 7,575 - 77.6 20,164 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 457 7,118 - 78.6 35,914 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 4,961 342 - 80.5 399,374 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 317 25 - 81.5 25,829 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 25 0 - 82.9 2,072 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 1,815 5,303 - 79.8 144,821 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 9,263 31,607 - - Stock Option (Right to Buy)
Vineet Agarwal Chief Financial Officer 17 Oct 2024 9,263 9,263 - 11.7 108,192 Common Stock
Vineet Agarwal Chief Financial Officer 17 Oct 2024 953 10,216 - 15.0 14,276 Common Stock
Jeffrey Cerio General Counsel 03 Sep 2024 40,000 40,000 - - Stock Option (Right to Buy)
Katharine Knobil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Aug 2024 9,041 9,041 - - Stock Option (Right to Buy)
Rachel Meyers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 5,190 5,190 - - Stock Option (Right to Buy)
David L. Lucchino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 5,190 5,190 - - Stock Option (Right to Buy)
Nessan Bermingham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 5,190 5,190 - - Stock Option (Right to Buy)
Ali Behbahani Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 5,190 5,190 - - Stock Option (Right to Buy)
Timothy R. Pearson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 5,190 5,190 - - Stock Option (Right to Buy)
Jean-Francois Formela Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 5,190 5,190 - - Stock Option (Right to Buy)
Olukemi Olugemo Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2024 65,000 65,000 - - Stock Option (Right to Buy)
Jean-Francois Formela Director Grant, award, or other acquisition of securities at price $ 56.00 per share. 22 Apr 2024 17,857 195,074 - 56 999,992 Common Stock
Ali Behbahani Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 56.00 per share. 22 Apr 2024 17,857 1,090,793 - 56 999,992 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters